Behavioral economics to improve lifestyle choices and to reduce risk factors.

[Behavioral economics to improve lifestyle choices and to reduce risk factors]. Gac Sanit. 2019 Aug 16;: Authors: Abellán JM, Jimenez-Gomez D Abstract A large part of morbimortality is caused by lifestyle habits and modifiable risk factors. A promising strategy to promote the change of such factors is the implementation of public health interventions based on behavioral economics, a discipline that combines psychological and economic principles. In the present article, we focus on a type of intervention known as "nudge" (that has been translated into Spanish as empujón or acicate), that changes behaviour without limiting the individual's choice. We analyze the properties that characterize nudges, and several areas in which they have been successfully implemented: vaccination, nutrition, physical activity, smoking cessation and drug prescription. We conclude that behavioural economics and nudges have great potential for their implementation in the public health sphere in Spain. PMID: 31427126 [PubMed - as supplied by publisher]
Source: Gaceta Sanitaria - Category: International Medicine & Public Health Tags: Gac Sanit Source Type: research

Related Links:

Publication date: Available online 13 November 2019Source: Veterinary MicrobiologyAuthor(s): Linlin Li, Yun Zhang, Jiawen Dong, Junqing Zhang, Chunhong Zhang, Minhua Sun, Yongchang CaoAbstractDuck Tembusu virus (DTMUV) is a major pathogen of duck industry in China. In the current study, we generated different constructs containing envelope (E) protein, pre-membrane-envelope (prM-E) protein, and C-terminally truncated E protein of the DTMUV. The constructed proteins could induce specific antibody responses in young ducks. When ducklings were immunized with the constructed proteins, they were 100% protected against DTMUV inf...
Source: Veterinary Microbiology - Category: Veterinary Research Source Type: research
Publication date: Available online 13 November 2019Source: PeptidesAuthor(s): Nigel Irwin, Victor A. Gault, Finbarr P.M. O’Harte, Peter R. FlattAbstractGastric inhibitory polypeptide (GIP) is a 42 amino acid hormone secreted from intestinal K-cells in response to nutrient ingestion. Despite a recognised physiological role for GIP as an insulin secretagogue to control postprandial blood glucose levels, growing evidence reveals important actions of GIP on adipocytes and promotion of fat deposition in tissues. As such, blockade of GIP receptor (GIPR) action has been proposed as a means to counter insulin resistance, and...
Source: Peptides - Category: Biochemistry Source Type: research
Publication date: Available online 12 November 2019Source: Preventive MedicineAuthor(s): Michelle I. Silver, Sarah KobrinAbstractThe human papillomavirus (HPV) vaccine is a powerful tool in cancer prevention. In combination with cervical cancer screening programs, this vaccine has the potential to nearly eliminate death from cervical cancer. However, this remarkable public health success can only be realized if vaccines reach those most at risk—unscreened women. Vaccinating only those already well-screened would have little impact on cervical cancer mortality, exacerbate disparities, and be a striking public health f...
Source: Preventive Medicine - Category: International Medicine & Public Health Source Type: research
Conditions:   Flu, Human;   Influenza, Human Intervention:   Behavioral: Video about safety and effectiveness of adult seasonal flu vaccination Sponsors:   Harvard University;   Stanford University;   Massachusetts Institute of Technology Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Pancreatic Cancer Interventions:   Drug: Atezolizumab;   Biological: RO7198457;   Drug: mFOLFIRINOX Sponsors:   Memorial Sloan Kettering Cancer Center;   Genentech, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Source: BMJ News - Category: General Medicine Source Type: research
[VOA] This week the European Commission gave approval to a Ebola vaccine -- an act that the World Health Organization calls landmark moment for global health and a likely game-changer in the battle against this deadly disease.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
Current challenges: from the path of "original antigenic sin" towards the development of universal flu vaccines. Int Rev Immunol. 2019 Nov 09;:1-16 Authors: Biswas A, Chakrabarti AK, Dutta S Abstract Annual flu led by influenza viruses is contemplated to be one of the foremost global health challenges due to its rapid spread leading to the life-threatening epidemic or pandemic. An enormous number of people die due to flu and its associated intricacies every year. Annual vaccination is considered to be the gold standard strategy to protect the individual from acquiring infection and further de...
Source: International Reviews of Immunology - Category: Allergy & Immunology Tags: Int Rev Immunol Source Type: research
(Deakin University) Researchers have narrowed down the malaria proteins and disease-fighting antibodies that could be used to develop a vaccine against the most severe forms of malaria.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
U.S. drugmaker Merck&Co Inc on Monday received approval from the European Commission to market its Ebola vaccine, less than a month after a European medicines panel backed the first-ever vaccine against the deadly virus.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
More News: Economics | International Medicine & Public Health | Nutrition | Psychology | Smokers | Spain Health | Vaccines